Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nasim Shweke"'
Publikováno v:
médecine/sciences. 29:1131-1137
Thrombospondin-1 (TSP-1) is a 450-kDa matricellar glycoprotein. By its various domains, it can interact with various partners and exhibit anti-angiogenic, pro-apoptotic and immunomodulatory activities. TSP-1 is also a major endogenous activator of th
Autor:
Jean-Paul Duong Van Huyen, Christian Hiesse, Véronique Frémeaux-Bacchi, Gaëlle Pellé, Sadika Hessaïne, Nasim Shweke, L. Tricot, Michel Delahousse
Publikováno v:
American Journal of Kidney Diseases. 57:756-759
Intravenous injection of angiogenesis-inhibitor drugs is used widely to treat cancers. Associated renal complications primarily involve proteinuria and hypertension, and thrombotic microangiopathies also have been described. Intravitreal anti-vascula
Autor:
Christos Chatziantoniou, Dominique Guerrot, Nasim Shweke, Christos E. Chadjichristos, Anne-Cecile Huby, Jean-Claude Dussaule, Jean-Jacques Boffa
Publikováno v:
International Journal of Experimental Pathology. 92:151-157
The need for novel insights into the mechanisms of progression of renal disease has become urgent during the last several years because of the increasing incidence of chronic renal disease worldwide. Independent of the underlying disease, the subsequ
Publikováno v:
Medecine sciences : M/S. 29(12)
Thrombospondin-1 (TSP-1) is a 450-kDa matricellar glycoprotein. By its various domains, it can interact with various partners and exhibit anti-angiogenic, pro-apoptotic and immunomodulatory activities. TSP-1 is also a major endogenous activator of th
Autor:
Sophie Vandermeersch, Naïke Bigé, Pierre Ronco, Safa Benhassine, Christos Chatziantoniou, Chantal Jouanneau, Jean-Jacques Boffa, Jean-Claude Dussaule, Nasim Shweke
Publikováno v:
Kidney International
Kidney International, 2012, 81 (12), pp.1226-38. ⟨10.1038/ki.2012.21⟩
Kidney International, Nature Publishing Group, 2012, 81 (12), pp.1226-38. ⟨10.1038/ki.2012.21⟩
Kidney International, 2012, 81 (12), pp.1226-38. ⟨10.1038/ki.2012.21⟩
Kidney International, Nature Publishing Group, 2012, 81 (12), pp.1226-38. ⟨10.1038/ki.2012.21⟩
International audience; Thrombospondin-1 (TSP-1) is an endogenous activator of transforming growth factor-β (TGF-β), and an anti-angiogenic factor, which may prevent kidney repair. Here we investigated whether TSP-1 is involved in the development o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c609daa8b3c19c0c146a376cb13e142
https://doi.org/10.1038/ki.2012.21
https://doi.org/10.1038/ki.2012.21
Autor:
Christos Chatziantoniou, Jean-Claude Dussaule, Chantal Jouanneau, Pierre Ronco, Nasim Shweke, Jean-Jacques Boffa, Fabrice Mihout, Naïke Bigé
Publikováno v:
The Journal of pathology. 223(1)
Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is accumulated in plasma during chronic kidney disease (CKD). It is considered an independent mortality and cardiovascular risk factor in CKD patients. To test t
Autor:
Sophie Vandermeersch, Chantal Jouanneau, Jean Claude Dussaule, Pierre Ronco, Jean Jacques Boffa, Gerry Melino, Christos Chatziantoniou, Nada Boulos, Nasim Shweke
Renal fibrosis is defined by the exaggerated accumulation of extracellular matrix proteins. Tissue transglutaminase (TG2) modifies the stability of extracellular matrix proteins and renders the extracellular matrix resistant to degradation. In additi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d94ca2ec2012ea618bd66886324831
https://europepmc.org/articles/PMC2527082/
https://europepmc.org/articles/PMC2527082/